Back to Journals » OncoTargets and Therapy » Volume 7

Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis

Total article views   HTML views PDF downloads Totals
10,355 Dovepress* 9,406+ 1,471 10,877
PubMed Central* 949 368 1,317
Totals 10,355 1,839 12,194
*Since 18 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar